English
This article is from Disease Models & Mechanisms , volume 5 . Abstract In September of 2011, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the International Rett Syndrome Foundation (IRSF) and the Rett Syndrome Research Trust (RSRT) convened a workshop involving a broad cross-section of basic scientists, clinicians and representatives from the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), the pharmaceutical industry and private foundations to assess the state of the art in animal studies of Rett syndrome (RTT). The aim of the workshop was to identify crucial knowledge gaps and to suggest scientific priorities and best practices for the use of animal models in preclinical evaluation of potential new RTT therapeutics. This review summarizes outcomes from the workshop and extensive follow-up discussions among participants, and includes: (1) a comprehensive summary of the physiological and behavioral phenotypes of RTT mouse models to date, and areas in which further phenotypic analyses are required to enhance the utility of these models f
Sign in with your free account to read, download EPUBs or listen.
Ebook · Preclinical research in Rett syndrome: setting the foundation for translational success. · Katz, David M., Berger-Sweeney, Joanne E., Eubanks, James H., Justice, Monica J., Neul, Jeffrey L., Pozzo-Miller, Lucas, Blue, Mary E., Christian, Diana · Internet Archive